CHEK2 and neoplasm: Correspondingly, the T-cell compartment associated with the low CHEK2 expressing tumor cells showed GO term enrichment for “T-cell-mediated cytotoxicity pathway” as compared to the T cells from high CHEK2 expressing tumor cells (p = 0.042; Fig. 4b) (Supplementary Data 1).